• Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 21 Dec 2024 03:22:12   America/New_York


    Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat December 21, 2024 Share Link copied to clipboard. Shares of Neurocrine Biosciences, Inc.
    Read more...
Share on,